Skip to main content
. Author manuscript; available in PMC: 2013 Jun 3.
Published in final edited form as: Cell Transplant. 2011 Apr 29;20(0):1915–1920. doi: 10.3727/096368911X566253

Figure 3. Both hCD47-LCL and pKS-LCL cells can survive and form tumors in macrophage-depleted NOD/SCID mice.

Figure 3

Macrophage-depleted NOD/SCID mice (n=3) were injected with hCD47-LCL and pKS-LCL cells into the subcapsular space of left (top panel) and right (bottom panel) kidney (5×107 per kidney), respectively. A. Flow cytometric analysis of hCD47-LCL (top) and pKS-LCL (bottom) cell inocula. B. Tumors found in left and right kidneys. C. Flow cytometric analysis of tumor cells from left and right kidneys.